Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York. Show more

Location: 1540 Broadway, 24th Floor, New York, NY, 10036, United States | Website: https://www.schrodinger.com | Industry: Health Information Services | Sector: Healthcare


Market Cap

1.538B

52 Wk Range

$16.60 - $28.47

Previous Close

$20.96

Open

$21.28

Volume

348,387

Day Range

$20.81 - $21.42

Enterprise Value

1.092B

Cash

500.3M

Avg Qtr Burn

N/A

Insider Ownership

2.63%

Institutional Own.

-

Qtr Updated

03/31/25


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.